The elevated levels of cardiac troponin I and inflammatory markers, a progressive trend towards a decline in LVEF, and the enlargement of the left ventricle over time in TTE, along with the findings from Cardiac T2-weighted magnetic resonance imaging and a right ventricular EMB, collectively supported the diagnosis of scleroderma myocarditis. Here, TNNI3 is linked to scleroderma.